Aclaris Therapeutics, Inc. (ACRS)

Aclaris Therapeutics Revenue

Aclaris Therapeutics had revenue of $2.40M in the quarter ending March 31, 2024, a decrease of -5.14%. This brings the company's revenue in the last twelve months to $31.12M, up 0.95% year-over-year. In the year 2023, Aclaris Therapeutics had annual revenue of $31.25M with 5.03% growth.

• Revenue (ttm): $31.12M
• Revenue Growth: +0.95%
• P/S Ratio: 3.18
• Revenue / Employee: $341,967
• Employees: 91
• Market Cap: 99.06M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	31.25M	1.50M	5.03%
Dec 31, 2022	29.75M	22.99M	340.05%
Dec 31, 2021	6.76M	279.00K	4.30%
Dec 31, 2020	6.48M	2.26M	53.35%
Dec 31, 2019	4.23M	-1.92M	-31.28%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.